NSE filing, NSE: LUPIN. Summary written from the filing by ALFA Finder's alert engine.
Lupin Ltd: key numbers
- Share price
- ₹2,011.00
- Market cap
- ₹91,962 Cr
- Revenue (annual)
- ₹27,958 Cr
- Net profit (annual)
- ₹5,333 Cr
- P/E (TTM)
- 16.6×Sector 45.9×
- Promoter holding
- 46.84%-0.01% QoQ
- FII holding
- 23.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lupin Ltd
All →Lupin Business Update
Lupin Limited disclosed that the U.S. FDA concluded an inspection at its Goa manufacturing facility, closing with a Form-483 containing one observation. The company will respond within the stipulated timeframe.
Lupin Management Change
Lupin Limited appointed Mr. Brian Savage as President and Chief Legal Officer, effective October 22, 2026. He will oversee global legal, compliance, and IP functions.
Lupin Employee Stock Options
Lupin Limited has granted 40,157 stock options to employees under its existing ESOP scheme at an exercise price of ₹2.00 per share.
Lupin Board Meeting Date
Lupin Limited scheduled a Board meeting on November 03, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Lupin Other Announcement
Lupin Limited received an ESG rating of 70 for FY26 from NSE Sustainability Ratings and Analytics. The assessment was independently prepared using publicly available information.
Lupin Regulatory Approval
Lupin Limited received U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Phytonadione Injectable Emulsion, USP (1 mg/0.5 mL single-dose prefilled syringe).
Other annual general meeting announcements
All →Quint Digital Annual General Meeting
Quint Digital Limited reported postal ballot results, with all resolutions approved by members on 31 October 2026. The scrutinizer's report and voting results are enclosed, and the resolution texts are not in the extract.
TeleCanor Global Annual General Meeting
TeleCanor Global held its 34th AGM on 31-Oct-2026 and the proceedings were filed with the exchange. Two ordinary resolutions were put to members, covering adoption of FY2026 accounts and re-appointment of a retiring director.
Sun Pharmaceutical Industries Annual General Meeting
Sun Pharma's postal ballot passed all seven special resolutions, including ESOP 2026 approval and borrowing and security limits. No monetary transaction is stated.
Bondada Engineering Annual General Meeting
Bondada Engineering Ltd has called an extraordinary general meeting on 21 November 2026. Shareholders will vote on related-party loans, security creation and borrowing limits.
Uflex Annual General Meeting
Uflex shareholders approved a special resolution to borrow up to ₹5,000 Crore under Section 180(1)(c) via postal ballot, with 99.92% in favour. The result was declared on 31 October 2026.
Stovec Industries Annual General Meeting
Stovec Industries' shareholders approved two non-executive director appointments by postal ballot. Both resolutions passed with about 98% of votes polled in favour.